however, the treatment is often limited by the availability of equipment (eg, hyperbaric oxygen)
Appendicitis is one of the leading causes of sudden severe abdominal pain requiring surgery in the United States, according to the National Institutes of Health (NIH)
Experts anticipate an approval filing could occur in late 2026 or 2027 following the conclusion of Phase 3 trials
We know thats an interest of people living with obesity. Novo Nordisks announcement comes as it faces increased pressure from Eli Lilly and compounding pharmacies, Evan Seigerman, a pharmaceutical analyst at BMO Capital Markets, wrote in a note to clients on Monday
300 SGLT-1/2i, sotagliflozin, reduced the risk of MACE by 16% in the SCORED trial in patients with chronic kidney disease and additional cardiovascular risk factors, and it is the only SGLT-i with evidence of a reduced risk of ASCVD-related macrovascular events of MI and stroke
Collect baseline and follow-up (e.g., 1, 3, 6, 12 months) vaginal symptom PROMs, vaginal pH, microbiome sequencing, HbA1c, hydration markers, sex hormones (oestradiol/estrone/SHBG), and weight trajectory